KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Shares Outstanding (Diluted Average) (2017 - 2025)

Historic Shares Outstanding (Diluted Average) for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $501.2 million.

  • Elanco Animal Health's Shares Outstanding (Diluted Average) rose 70.32% to $501.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $501.2 million, marking a year-over-year increase of 70.32%. This contributed to the annual value of $497.3 million for FY2024, which is 101.56% up from last year.
  • As of Q3 2025, Elanco Animal Health's Shares Outstanding (Diluted Average) stood at $501.2 million, which was up 70.32% from $500.1 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Shares Outstanding (Diluted Average) registered a high of $501.2 million during Q3 2025, and its lowest value of $486.7 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $492.7 million (2023), whereas its average is $492.9 million.
  • In the last 5 years, Elanco Animal Health's Shares Outstanding (Diluted Average) soared by 2050.01% in 2021 and then rose by 12.19% in 2023.
  • Quarter analysis of 5 years shows Elanco Animal Health's Shares Outstanding (Diluted Average) stood at $487.2 million in 2021, then rose by 0.23% to $488.3 million in 2022, then increased by 0.82% to $492.3 million in 2023, then rose by 1.02% to $497.3 million in 2024, then increased by 0.78% to $501.2 million in 2025.
  • Its last three reported values are $501.2 million in Q3 2025, $500.1 million for Q2 2025, and $499.1 million during Q1 2025.